Mirae Asset Global Investments
XBI icon

Mirae Asset Global Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mirae Asset Global Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,943
Closed -$376K – 1756
2026
Q1 		$376K Sell
2,943
-23,627
-89% -$2.95M ﹤0.01% 986
2025
Q4 		$3.24M Buy
26,570
+13,729
+107% +$1.57M 0.01% 672
2025
Q3 		$1.29M Buy
+12,841
New +$1.16M ﹤0.01% 845
2025
Q1 		– Sell
-3,278
Closed -$299K – 1673
2024
Q4 		$299K Sell
3,278
-18,112
-85% -$1.75M ﹤0.01% 1007
2024
Q3 		$1.3M Buy
21,390
+2,997
+16% +$294K 0.01% 752
2024
Q2 		$1.19M Sell
18,393
-10,927
-37% -$980K 0.01% 712
2024
Q1 		$2.78M Buy
29,320
+3,860
+15% +$358K 0.01% 1050
2023
Q4 		$2.27M Buy
25,460
+14,449
+131% +$1.07M ﹤0.01% 1200
2023
Q3 		$804K Sell
11,011
-9,600
-47% -$767K ﹤0.01% 1639
2023
Q2 		$1.71M Buy
+20,611
New +$1.72M ﹤0.01% 1283
2023
Q1 		– Sell
-13,300
Closed -$1.1M – 2584
2022
Q4 		$1.1M Buy
+13,300
New +$1.08M ﹤0.01% 1438
2022
Q1 		– Sell
-48,590
Closed -$5.44M – 1646
2021
Q4 		$5.44M Sell
48,590
-33,100
-41% -$3.99M 0.01% 864
2021
Q3 		$10.3M Sell
81,690
-108,900
-57% -$14M 0.03% 638
2021
Q2 		$25.8M Buy
190,590
+161,600
+557% +$21.2M 0.07% 334
2021
Q1 		$3.93M Sell
28,990
-171,400
-86% -$25.7M 0.01% 786
2020
Q4 		$28.2M Buy
200,390
+79,600
+66% +$10.2M 0.1% 236
2020
Q3 		$13.5M Buy
120,790
+114,700
+1,883% +$12.9M 0.07% 322
2020
Q2 		$682K Buy
6,090
+810
+15% +$79.8K ﹤0.01% 1039
2020
Q1 		$409K Sell
5,280
-105,950
-95% -$9.38M ﹤0.01% 1087
2019
Q4 		$10.6M Buy
111,230
+54,990
+98% +$4.76M 0.07% 338
2019
Q3 		$4.29M Sell
56,240
-12,480
-18% -$1.04M 0.03% 503
2019
Q2 		$6.03M Buy
68,720
+54,500
+383% +$4.65M 0.04% 421
2019
Q1 		$1.29M Buy
14,220
+1,220
+9% +$104K 0.01% 755
2018
Q4 		$933K Hold
13,000
– – 0.01% 783
2018
Q3 		$1.25M Sell
13,000
-120
-0.9% -$11.6K 0.01% 777
2018
Q2 		$1.25M Sell
13,120
-320,801
-96% -$29.5M 0.02% 473
2018
Q1 		$29.3M Buy
+333,921
New +$30.5M 0.38% 62
2016
Q4 		– Sell
-5,500
Closed -$365K – 563
2016
Q3 		$365K Sell
5,500
-3,400
-38% -$210K 0.01% 477
2016
Q2 		$481K Buy
8,900
+2,100
+31% +$115K 0.01% 408
2016
Q1 		$351K Sell
6,800
-10,900
-62% -$566K 0.01% 407
2015
Q4 		$1.24M Sell
17,700
-6,600
-27% -$450K 0.04% 295
2015
Q3 		$1.51M Buy
24,300
+11,250
+86% +$887K 0.06% 244
2015
Q2 		$1.1M Sell
13,050
-150
-1% -$11.7K 0.04% 299
2015
Q1 		$992K Buy
+13,200
New +$922K 0.03% 299
2014
Q4 		– Sell
-48,021
Closed -$2.5M – 479
2014
Q3 		$2.5M Sell
48,021
-471
-1% -$24K 0.09% 136
2014
Q2 		$2.49M Sell
48,492
-2,155,440
-98% -$97.2M 0.06% 134
2014
Q1 		$105M Buy
2,203,932
+1,544,862
+234% +$79.1M 2.66% 12
2013
Q4 		$28.6M Sell
659,070
-399,726
-38% -$16.5M 1.2% 25
2013
Q3 		$45.4M Buy
1,058,796
+13,758
+1% +$557K 2.05% 14
2013
Q2 		$36.3M Buy
+1,045,038
New +$36.7M 1.92% 16

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

Mirae Asset Global Investments's XBI Position: Q2 2026 in Review

Mirae Asset Global Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 2,943 shares — an estimated $376K sold.

Mirae Asset Global Investments first reported a position in XBI in Q2 2013 and held it in 40 quarters. The position peaked at $105M in Q1 2014. 416 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Mirae Asset Global Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,943 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $376K.
  • Mirae Asset Global Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 40 quarters.
  • Mirae Asset Global Investments's State Street SPDR S&P Biotech ETF position peaked at $105M in Q1 2014.
  • 416 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.